NCT07183657 Adherence to Inhaled Therapy - a Globally Overlooked Problem in Patients With Chronic Obstructive Pulmonary Disease and Bronchial Asthma
| NCT ID | NCT07183657 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Charles University, Czech Republic |
| Condition | Chronic Obstructive Pulmonary Disease (COPD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2025-06-03 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2025-06-03 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Comprehensive assessment and interventions to promote adherence to inhaled therapy in patients with bronchial asthma and chronic obstructive pulmonary disease involving health care professionals caring for these patients in different settings and using the Five Steps Assessment tool and artificial intelligence methods and tools.
Eligibility Criteria
PATIENTS Inclusion Criteria: 1. signed informed consent, 2. age ≥ 18 years, 3. previously diagnosed BA/COPD meeting GOLD 2024 and GINA 2024 diagnostic criteria, 4. ability to cooperate, 5. at least 8 weeks without exacerbation, 6. use of a particular inhaler for at least 3 months. Exclusion Criteria: 1. pre-terminal/terminal stage of any disease, 2. uncooperative patient, 3. significant limitation of mobility or cognitive functions. HEALTHCARE PROFESSIONALS Inclusion Criteria: 1. signed informed consent, 2. completed education in medicine, pharmacy, or nursing, 3. more than one year of working experience, 4. care for patients taking inhaled therapy for BA/COPD.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07183657 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Obstructive Pulmonary Disease (COPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07183657 currently recruiting?
Yes, NCT07183657 is actively recruiting participants. Contact the research team at malyj@faf.cuni.cz for enrollment information.
Where is the NCT07183657 trial being conducted?
This trial is being conducted at Hradec Králové, Czechia.
Who is sponsoring the NCT07183657 clinical trial?
NCT07183657 is sponsored by Charles University, Czech Republic. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.